Monaghan G, Ryan M, Seddon R, Hume R, Burchell B
Department of Biochemical Medicine, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
Lancet. 1996 Mar 2;347(9001):578-81. doi: 10.1016/s0140-6736(96)91273-8.
The genetic basis of Gilbert's syndrome is ill-defined. This common mild hyperbilirubinaemia sometimes presents as an intermittent jaundice. A reduced hepatic bilirubin UPD- glucuronosyltransferase (UGT) is associated with this syndrome. We have examined variation in the gene encoding the UGT1*1 enzyme and serum bilirubin levels in a Scottish population.
Blood was collected from 12 patients with confirmed or suspected Gilbert's syndrome, from 6 members of a family with 4 Gilbert members, and from 77 non-smoking, alcohol-free, drug-free volunteers recruited from the staff of a teaching hospital in Dundee. Polymerase chain reaction amplification was used to examine sequence variation of the promoter upstream of the UGT1*1 exon I. Genotypes were assigned as follows: 6/6 (homozygous for a common allele bearing the sequence TATAA), 7/7 (homozygous for a rarer allele with the sequence TATAA), and 6/7 (heterozygous with one of each allele).
Individuals in the population with the 7/7 genotype had significantly higher bilirubin concentrations than those who had the 6/7 or 6/6 genotype. 14 volunteers underwent a 24 h fasting test to see if they had Gilbert's syndrome, and all four positives had the 7/7 genotype. One confirmed Gilbert's patient, two recurrent jaundice patients (with suspected Gilbert's syndrome), and nine clinically diagnosed cases had the 7/7 genotype. Segregation of the 7/7 genotype with the Gilbert phenotype was also demonstrated in the family with four affected members. The frequency of the 7/7 genotype in this eastern Scottish population was 10-13%.
In a healthy population there was an association between variation in bilirubin concentration and a mutation within the gene encoding the enzyme bilirubin UGT. This and other findings suggest the existence of a mild and a more severe form of Gilbert's syndrome, depending on whether the gene defect lies in the promoter sequence upstream of UGT1*I exon I, as here (mild), or in the coding sequence (severe) of the gene.
吉尔伯特综合征的遗传基础尚不明确。这种常见的轻度高胆红素血症有时表现为间歇性黄疸。肝脏胆红素UDP - 葡萄糖醛酸基转移酶(UGT)活性降低与该综合征有关。我们在一个苏格兰人群中研究了编码UGT1*1酶的基因变异和血清胆红素水平。
采集了12例确诊或疑似吉尔伯特综合征患者的血液、一个有4名吉尔伯特综合征患者的家族中6名成员的血液,以及从邓迪一家教学医院工作人员中招募的77名不吸烟、不饮酒、未使用药物的志愿者的血液。采用聚合酶链反应扩增检测UGT1*1外显子I上游启动子的序列变异。基因型分类如下:6/6(携带序列TATAA的常见等位基因纯合子)、7/7(携带序列TATAA的罕见等位基因纯合子)和6/7(每个等位基因各一个的杂合子)。
该人群中7/7基因型个体的胆红素浓度显著高于6/7或6/6基因型个体。14名志愿者接受了24小时禁食试验以确定是否患有吉尔伯特综合征,所有4名阳性者均为7/7基因型。1例确诊的吉尔伯特综合征患者、2例复发性黄疸患者(疑似吉尔伯特综合征)和9例临床诊断病例为7/7基因型。在一个有4名患病成员的家族中也证实了7/7基因型与吉尔伯特表型的分离。在这个苏格兰东部人群中,7/7基因型的频率为10 - 13%。
在健康人群中,胆红素浓度变异与编码胆红素UGT酶的基因突变之间存在关联。这一发现及其他研究结果表明,吉尔伯特综合征存在轻度和重度两种形式,这取决于基因缺陷是位于UGT1*I外显子I上游的启动子序列(如本研究中的轻度形式)还是基因的编码序列(重度形式)。